Abstract
The field of pediatric neuro-oncology research has undergone succession of rapid advances in the past ten years at an incredible pace. Most of these advances were driven by genomic and epigenomic characterizations of large cohort of samples assembled through international collaboration. As a result of these efforts, robust molecular markers of several types of pediatric brain tumors have been developed for diagnostic and prognostic applications.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
